Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
US7714105B2 · kind B2 · utility
3Cited by
2References
8Claims
0Family size
Inventors
Key dates
| Filing date | Jun 19, 2002 |
| Grant date | May 11, 2010 |
| Priority date | — |
| Expiry date | Jan 18, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use di-, tri- and tetrapeptide fragments of oxytocin or mesotocin for the preparation of a pharmaceutical composition in order to create eustasis. The invention also relates to di-, tri- and tetrapeptide fragments of oxytocin or mesotocin for medical use, as well as a pharmaceutical composition comprising at least one di-, tri- or tetrapeptide fragment of oxytocin or mesotocin in order to create eustasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.